• About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • Therapeutic Focuses
    • Technologies
    • Partnerships / Collaborations
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships / Collaborations
  • Media-Center
    • For Media
    • News
  • Contacts
  • Eng
    • Рус
    • Укр
  • Eng
    • Рус
    • Укр
  • About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • Therapeutic Focuses
    • Technologies
    • Partnerships / Collaborations
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships / Collaborations
  • Media-Center
    • For Media
    • News
  • Contacts
Головна » Therapy of exacerbations of bronchial asthma and COPD
Category

Filter

  • First column
    • All products
    • New products
    • Infusion therapy
      • Acid-basbalance correctorse
      • Antishock solutions
      • Clinical nutrition
      • Detoxification therapy
      • Microcirculation and rheology disorder correctors
      • Osmotic diuretics
      • Water-electrolyte balance correctors
      • Special effect medications
      • Therapy of exacerbations of asthma and COPD
    • Simple infusion solutions
    • Dialysis
  • Second column
    • Antibacterial and fungicidal solutions
    • Antiviral solutions
    • Antiseptics and irrigating solutions
    • Multimodal analgesia
    • Antituberculosis drugs
    • Breather System
    • Ulaizer
      • Ulaizer nebulizers
      • Nebulizer accessories
      • Nebulizer medications
    • Innovative hyaluronic acid based products
  • Third column
    • Medical Devices
      • Syringes
      • Systems
      • Regional anaesthesia
      • Infusion cannulas
      • Implantable system U-PORT
      • YURiA-PHARM gloves
      • Woven bandage
    • Home Medicine Cabinet
      • Water fot hydration and detoxication
      • Water for taking medications
      • Ophthalmic agents
      • Antihaemorrhagic agents
      • Anti-influenza and anti-ARVI drugs
      • Disinfectants
      • For heart and vessels
      • For bowel movement

Derkast®

DERKAST® — is the only parenteral phosphodiesterase inhibitor reversing at the same time two pathogenetic failures - bronchospasm and inflammation at patients with asthma exacerbation and chronic obstructive pulmonary disease.

This site uses cookies to give you a better browsing experience, you can find out more about the cookies we use here Confidentiality Policy
Accept

Sign for health professionals

If you are a health care professional, as a confirmation, press «ENTER» to get started.
  • About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • Therapeutic Focuses
    • Technologies
    • Partnerships / Collaborations
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships / Collaborations
  • Media-Center
    • For Media
    • News
  • Contacts
  • Confidentiality Policy
Feedback
  • Product sites:
    • Instylan (EN, IT, ES, FR, PL)
    • Xavron (EN)
    • Tivortin (EN)
    • Ulaizer (EN)
    • Revul (EN)
Follow us

Contact form

    Delete
    Delete
    Delete
    Delete
    Delete